Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

Biogeneric Debate Likely For 2007 Congressional Session

Dec. 26, 2006

By Aaron Lorenzo

Industry Mulling Movement Toward Price Transparency

Dec. 22, 2006

By Aaron Lorenzo

Industry Mulling Movement Toward Price Transparency

Dec. 22, 2006

By Aaron Lorenzo

Orexigen Files IPO To Fund Its Obesity-Fighting Drugs

Dec. 21, 2006

By Aaron Lorenzo

HHS Ends VaxGen's $877.5M Contract On Anthrax Vaccine

Dec. 21, 2006

By Aaron Lorenzo

HHS Ends VaxGen's $877.5M Contract On Anthrax Vaccine

Dec. 21, 2006

By Aaron Lorenzo

Orexigen Files IPO To Fund Its Obesity-Fighting Drugs

Dec. 21, 2006

By Aaron Lorenzo

Orphan Pressing Ahead With Lucassin NDA For Type I HRS

Dec. 20, 2006

By Aaron Lorenzo

Orphan Pressing Ahead With Lucassin NDA For Type I HRS

Dec. 20, 2006

By Aaron Lorenzo

FDA Gives Nod To BioSante's Estrogen Drug In Hot Flashes

Dec. 19, 2006

By Aaron Lorenzo

View All Articles by Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 8, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
GLP-1 receptor agonists continue their global victory tour
BioWorld
2024 was another banner year for GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their...
AI drives financings, approvals for APAC med-tech in 2024
BioWorld MedTech
AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.